Yahoo Finance • 20 days ago
Apogee Enterprises, Inc. (NASDAQ:APOG) is one of the best dividend stocks to buy. As of December 5, the average price target for APOG suggests an upside of 27%, however, the Street high indicates an upside of 62%. Previously, on November... Full story
Yahoo Finance • 28 days ago
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. Luckily for you, we built StockStory t... Full story
Yahoo Finance • 2 months ago
Water heating and treatment solutions company A.O. Smith (NYSE:AOS) will be reporting results this Tuesday before the bell. Here’s what you need to know. A. O. Smith beat analysts’ revenue expectations by 1.2% last quarter, reporting reve... Full story
Yahoo Finance • 3 months ago
* Apogee press release [https://seekingalpha.com/pr/20261704-apogee-enterprises-reports-fiscal-2026-second-quarter-results] (NASDAQ:APOG [https://seekingalpha.com/symbol/APOG]): Q2 Non-GAAP EPS of $0.98 beats by $0.14. * Revenue of $35... Full story
Yahoo Finance • 3 months ago
(RTTNews) - Apogee Enterprises Inc. (APOG) announced earnings for second quarter that Drops, from last year The company's earnings totaled $23.65 million, or $1.10 per share. This compares with $30.57 million, or $1.40 per share, last ye... Full story
Yahoo Finance • 3 months ago
The S&P 500 Index ($SPX) (SPY) today is down -0.24%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.36%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.32%. December E-mini S&P futures (ESZ25) are down -0.26%, and December E-... Full story
Yahoo Finance • 3 months ago
The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is down -0.07%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures... Full story
Yahoo Finance • 3 months ago
Major earnings expected after the bell on Thursday include: * Apogee Enterprises (APOG [https://seekingalpha.com/symbol/APOG]) * Applied Digital Corporation (APLD [https://seekingalpha.com/symbol/APLD]) * Levi Strauss & Co. (LEVI [h... Full story
Yahoo Finance • 3 months ago
December S&P 500 E-Mini futures (ESZ25 [https://www.barchart.com/futures/quotes/ESZ25]) are up +0.01%, and December Nasdaq 100 E-Mini futures (NQZ25 [https://www.barchart.com/futures/quotes/NQZ25/overview]) are down -0.03% this morning, st... Full story
Yahoo Finance • 3 months ago
[Third Quarter Q3 Profits Stock Trading Chart 3D Background] filo The upcoming first full week of October marks the beginning of the Q3 earnings season, with several notable names across consumer and technology set to report. Investors w... Full story
Yahoo Finance • 3 months ago
[Data analytics dashboard display. Business and financial investment. HUD infographic of financial. Information reports of business strategy for investment. 3d rendering] KanawatTH/iStock via Getty Images Wall Street's major averages cl... Full story
Yahoo Finance • 4 months ago
In March 2024, InvestingPro’s Fair Value model identified (NASDAQ:APGE) as significantly overvalued at $66.54, challenging the prevailing bullish sentiment. Today’s analysis validates that contrarian call, with the stock trading at $38.30,... Full story
Yahoo Finance • 5 months ago
MINNEAPOLIS - Apogee Enterprises, Inc. (NASDAQ:APOG), a profitable company with a market capitalization of $891 million and currently trading below its InvestingPro Fair Value, announced Thursday the appointment of two new business segment... Full story
Yahoo Finance • 6 months ago
Investing.com - UBS raised its price target on Regeneron Pharmaceuticals (NASDAQ:REGN) to $584.00 from $560.00 while maintaining a Neutral rating on the stock. According to InvestingPro data, Regeneron currently trades at a P/E ratio of 13... Full story
Yahoo Finance • 6 months ago
Investing.com - Stifel has reiterated its Buy rating and $95.00 price target on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE) following recent Phase 2a data for its atopic dermatitis (AD) treatment APG777. According to InvestingPro d... Full story
Yahoo Finance • 6 months ago
Investing.com - Bernstein SocGen Group has reiterated an Outperform rating on Regeneron Pharmaceuticals (NASDAQ:REGN) with a price target of $750.00. The company, currently trading at a PEG ratio of 0.77, shows strong potential with a "GRE... Full story
Yahoo Finance • 6 months ago
Investing.com - Canaccord Genuity has reiterated its Buy rating and $89.00 price target on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE) following positive clinical trial results for its atopic dermatitis treatment. The target repres... Full story
Yahoo Finance • 6 months ago
Investing.com - Citi maintained its Buy rating and $95.00 price target on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE), a $2.77 billion market cap biotech company, following the release of Phase 2a data for its atopic dermatitis tre... Full story
Yahoo Finance • 6 months ago
Monday’s trading session is showcasing significant movements across various market cap categories. Mega-cap giants like Tesla Motors (NASDAQ:TSLA) and Palantir Technologies Inc (NASDAQ:PLTR) have experienced notable shifts, while large... Full story
Yahoo Finance • 6 months ago
Thursday’s trading session is presenting a dynamic landscape for investors as stocks across the market cap spectrum experience significant movements. Mega-cap stocks like Servicenow Inc (NYSE:NOW) and Oracle Corp (NYSE:ORCL) are showin... Full story